Analysis Metabolite Name Measured Value Units CASE_CONTROL Chemotherapy Drug Race TIMEPOINT Tamoxyfen Taxane
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-6939Peak areaControl N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-19054Peak areaCase Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase N Exemestane Black 3 Month N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase N Exemestane Black Baseline N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase N Letrozole Black 3 Month N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase N Letrozole Black Baseline N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase Y Exemestane Black 3 Month N Y
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase Y Exemestane Black Baseline N Y
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase Y Exemestane White 3 Month Y Y
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase Y Exemestane White Baseline Y Y
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaCase Y Letrozole White Baseline Y Y
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl N Exemestane Black 3 Month Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl N Exemestane Black Baseline Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl N Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl N Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl N Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl N Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl N Letrozole Black 3 Month N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl N Letrozole Black Baseline N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl N Letrozole White 3 Month N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl N Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl N Letrozole White Baseline N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl N Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl Y Exemestane White 3 Month N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl Y Exemestane White 3 Month N Y
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl Y Exemestane White 3 Month Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl Y Exemestane White 3 Month Y Y
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl Y Exemestane White Baseline N N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl Y Exemestane White Baseline N Y
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl Y Exemestane White Baseline Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl Y Exemestane White Baseline Y Y
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl Y Letrozole White 3 Month Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl Y Letrozole White 3 Month Y Y
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl Y Letrozole White Baseline Y N
Reversed phase NEGATIVE ION MODEALPHA-KETO-GLUTARATE (CAS# 328-50-7); (M-H)-Peak areaControl Y Letrozole White Baseline Y Y

Return to search page
  logo